These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Severe upper gastrointestinal bleeding during treatment with rofecoxib for osteoarthritis. Caroli A; Monica F Am J Gastroenterol; 2001 May; 96(5):1663-5. PubMed ID: 11374736 [No Abstract] [Full Text] [Related]
4. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex). Wynn RL Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547 [No Abstract] [Full Text] [Related]
5. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG; Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361 [TBL] [Abstract][Full Text] [Related]
7. COX-2 inhibitors: new drugs for the management of pain and inflammation. Hutchins V; Hutchins B Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847 [No Abstract] [Full Text] [Related]
9. COX-2 inhibitors. Brooks PM; Day RO Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies. Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP; J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774 [TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs in orofacial pain management--an update. van der Bijl P; van der Bijl P SADJ; 2002 Aug; 57(8):328-31. PubMed ID: 12428528 [No Abstract] [Full Text] [Related]
12. Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints. Bolognese JA; Ehrich EW; Schnitzer TJ J Rheumatol; 2001 Dec; 28(12):2700-4. PubMed ID: 11764220 [TBL] [Abstract][Full Text] [Related]
13. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib. Steinfeld S; Bjørke PA Rheumatology (Oxford); 2002 Apr; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277 [TBL] [Abstract][Full Text] [Related]
14. Arthritis: what it is, why you get it and how to stop the pain. Adler J Newsweek; 2001 Sep; 138(10):38-46. PubMed ID: 11550612 [No Abstract] [Full Text] [Related]
15. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial. Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 enzyme inhibitors: place in therapy. Noble SL; King DS; Olutade JI Am Fam Physician; 2000 Jun; 61(12):3669-76. PubMed ID: 10892637 [TBL] [Abstract][Full Text] [Related]
17. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial. Gibofsky A; Williams GW; McKenna F; Fort JG Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272 [TBL] [Abstract][Full Text] [Related]
18. [Already the drug of choices in the USA. Coxibe in joint pain]. MMW Fortschr Med; 2002 Aug; 144(31-32):53. PubMed ID: 12422738 [No Abstract] [Full Text] [Related]
19. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Weir MR; Sperling RS; Reicin A; Gertz BJ Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311 [TBL] [Abstract][Full Text] [Related]
20. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary]. MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296 [No Abstract] [Full Text] [Related] [Next] [New Search]